GAST and gastroesophageal reflux disease: For example, gastrin has low utility as a biomarker since secretion is elevated in low acid conditions like CAG, during persistent Helicobacter pylori infection [9], or through use of proton pump inhibitors (PPIs) for e.g., gastroesophageal reflux disease (GERD) [6].